Protocol: Aspirin AM or PM?: effect on circadian rhythm of platelet reactivity”

• Conditions: platelet reactivity; Therapeutic area: Body processes [G] - Biological Phenomena [G16]

• Registration Number: EUCTR2013-001410-16-NL
• Lead Sponsor: etherlands Heart Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-06-27
• Last Update Posted: 15 July 2013

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

•Healthy subject
•Age >18yrs
•Capacity to give informed consent (IC)

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 11
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 1

Exclusion Criteria

•Active chronic disease
•Use of any other medication
•History of: major bleeding events, cardiovascular disease, malignancy
•Platelet count < 150 * 109/L
•VerifyNow Aspirin Reaction Units <550 ARU
•Smoking
•Shift workers
•Extreme chronotypes
•Pregnancy

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified